Immunovant Inc (IMVT) Insider Trading
- $73,590,865.28
- $15,341,014.48
- Oct. 23, 2024
- Peter Salzmann
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 12, 2023 | CEO | 3,233 | $19.73 | Sell | $63,787.09 | |
July 12, 2023 | Insider | 1,470 | $19.73 | Sell | $29,003.10 | |
April 25, 2023 | Insider | 509 | $16.29 | Sell | $8,291.61 | |
April 18, 2023 | CEO | 3,395 | $15.27 | Sell | $51,841.65 | |
April 18, 2023 | CFO | 3,423 | $15.27 | Sell | $52,269.21 | |
April 18, 2023 | Insider | 1,544 | $15.27 | Sell | $23,576.88 | |
Feb. 2, 2023 | Insider | 537 | $18.24 | Sell | $9,794.88 | |
Jan. 26, 2023 | Insider | 10,156 | $18.51 | Sell | $187,987.56 | |
Jan. 11, 2023 | CFO | 4,510 | $16.75 | Sell | $75,542.50 | |
Jan. 11, 2023 | CEO | 4,021 | $16.80 | Sell | $67,552.80 | |
Jan. 11, 2023 | Insider | 60,490 | $16.79 | Sell | $1,015,627.10 | |
Oct. 21, 2022 | Insider | 341 | $9.67 | Sell | $3,297.47 | |
Oct. 13, 2022 | Insider | 928 | $9.18 | Sell | $8,519.04 | |
Oct. 13, 2022 | CEO | 2,793 | $9.18 | Sell | $25,639.74 | |
Oct. 11, 2022 | CFO | 12,500 | $9.44 | Sell | $118,000.00 | |
Oct. 6, 2022 | Major Shareholder | 416,667 | $6.00 | Buy | $2,500,002.00 | |
Sept. 29, 2022 | Director | 20,000 | $5.81 | Buy | $116,200.00 | |
Sept. 28, 2022 | CEO | 1,605 | $4.67 | Sell | $7,495.35 | |
Sept. 28, 2022 | Insider | 535 | $4.67 | Sell | $2,498.45 | |
Aug. 30, 2022 | Insider | 548 | $5.83 | Sell | $3,194.84 | |
Aug. 30, 2022 | CEO | 1,644 | $5.83 | Sell | $9,584.52 | |
July 27, 2022 | Insider | 510 | $4.27 | Sell | $2,177.70 | |
July 27, 2022 | CEO | 1,528 | $4.27 | Sell | $6,524.56 | |
July 22, 2022 | Insider | 322 | $4.70 | Sell | $1,513.40 | |
June 29, 2022 | CEO | 1,376 | $4.02 | Sell | $5,531.52 | |
June 29, 2022 | Insider | 460 | $4.02 | Sell | $1,849.20 | |
May 24, 2022 | Insider | 492 | $3.79 | Sell | $1,864.68 | |
May 24, 2022 | CEO | 1,471 | $3.79 | Sell | $5,575.09 | |
April 27, 2022 | Insider | 541 | $4.72 | Sell | $2,553.52 | |
April 27, 2022 | CEO | 1,622 | $4.72 | Sell | $7,655.84 | |
April 19, 2022 | Insider | 1,392 | $4.98 | Sell | $6,932.16 | |
March 24, 2022 | CEO | 19,227 | $5.90 | Sell | $113,439.30 | |
March 24, 2022 | Insider | 6,381 | $5.90 | Sell | $37,647.90 | |
Jan. 5, 2022 | Insider | 26,813 | $8.28 | Sell | $222,011.64 | |
Aug. 27, 2021 | Director | 18,247 | $8.24 | Buy | $150,355.28 | |
Aug. 20, 2021 | Director | 7,000 | $7.65 | Buy | $53,550.00 | |
Aug. 13, 2021 | Director | 5,000 | $7.98 | Buy | $39,900.00 | |
Sept. 11, 2020 | Insider | 5,000 | $38.17 | Buy | $190,850.00 | |
Sept. 4, 2020 | Major Shareholder | 380,000 | $33.00 | Buy | $12,540,000.00 |
Insiders are both buying and selling Immunovant Inc stock.
The insider traders at Immunovant Inc are: Peter Salzmann, Julia G Butchko, Eva Renee Barnett, William L Macias, Mark S Levine, Jay S Stout, Sciences Ltd. Roivant, Michael Geffner, Atul Pande, Frank Torti, Douglas J Hughes, and George V Migausky
The most active insider trader at Immunovant Inc is Peter Salzmann with 24 trades.
Peter Salzmann has sold the most Immunovant Inc stock with a total value of $9,555,857.99.
Sciences Ltd. Roivant has bought the most Immunovant Inc stock with a total value of $131,040,018.00.
The most recent insider trade for Immunovant Inc was on Oct. 23, 2024.
The single biggest insider buy for Immunovant Inc was from Sciences Ltd. Roivant with a total value of $58,000,008.00 on Oct. 2, 2023.
The single biggest insider sell for Immunovant Inc was from Peter Salzmann with a total value of $2,207,502.36 on Aug. 14, 2023.